IMPACT OF THE NUTRITIONAL APPROACH IN PATIENTS WITH PARKINSON'S NEURODEGENERATIVE DISEASE; LITERATURE REVIEW
Main Article Content
Keywords
Parkinson's, Nutritional approach, Dysphagia, Food supplements
Abstract
Introduction: Malnutrition in the context of Parkinson's disease involves both excess and deficiency, with deficiency recognized as a prominent global cause of immunodeficiency. Various risk factors, including weight loss, levodopa treatment duration, anxiety, and symptoms related to dysautonomia, contribute to malnutrition in Parkinson's patients.
Objective: This study aims to delineate the impact of nutritional interventions on individuals with neurodegenerative Parkinson's disease.
Methodology: Conducted as a retrospective descriptive bibliographic review, the study involves a comprehensive search and analysis of original scientific articles in Spanish and English. Medical information databases such as PubMed, Web of Science, BVS, Scholar, Medline, SciELO, etc., were utilized for article selection.
Results: Out of 37 screened scientific articles, nine high-level evidence surveys were included, following predefined inclusion and exclusion criteria. The nutritional approach to Parkinson's involves guided diets tailored to the patient's nutritional status and disease progression. The Mediterranean diet emerges as a well-supported option for nutritional support in Parkinson's, along with recommendations for diet modification in the consistency of both liquids and solids.
Conclusion: This review underscores the importance of addressing malnutrition in Parkinson's disease through a targeted nutritional approach. Guided diets, especially those aligned with the principles of the Mediterranean diet, are recognized as valuable strategies. Modification of diet consistency, considering the progression of the disease, further adds to the nuanced nutritional management of Parkinson's patients.
References
1. Al-Hakeem, H., Zhang, Z., DeMarco, E. C., Bitter, C. C., & Hinyard, L. (2024). Emergency department visits in Parkinson's disease: The impact of comorbid conditions. The American Journal of Emergency Medicine, 75, 7-13.
2. Arunachalam, K. D., Saranya, S., & Karuppannan, S. K. (2024). Role of dietary fibres in the management of hypertension and its association with neurodegeneration Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 261-275): Elsevier.
3. Banou, E., Vrahatis, A. G., Krokidis, M. G., & Vlamos, P. (2024). Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease. BioMedInformatics, 4(1), 127-138.
4. Bartolomeu Pires, S., Kunkel, D., Kipps, C., Goodwin, N., & Portillo, M. C. (2024). Person‐centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review. Health Expectations, 27(1), e13948.
5. Cabanillas, J., Risco, R., Munive-Degregori, A., Guerrero, M. E., Mauricio, F., & Mayta-Tovalino, F. Periodontitis and neuropathic diseases: A literature review. Journal of International Society of Preventive and Community Dentistry, 10.4103.
6. Caminiti, S. P., Gallo, S., Menegon, F., Naldi, A., Comi, C., & Tondo, G. (2024). Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
7. Chen, S. T., & Small, G. W. (2024). Precision Nutrition in Aging and Brain Health Precision Nutrition (pp. 241-276): Elsevier.
8. Cheng, W.-H., Quan, Y., & Thompson, W. F. (2024). The Effect of Dance on Mental Health and Quality of Life of People with Parkinson's Disease: A Systematic Review and Three-level Meta-Analysis. Archives of Gerontology and Geriatrics, 105326.
9. Chiang, L., Cheong, D., Cordato, N. J., & Smerdely, P. (2024). A systematic review of visual art therapy and its effects in older people with mild cognitive impairment. International Journal of Geriatric Psychiatry, 39(1), e6053.
10. Ciocca, M., & Pizzamiglio, C. (2024). Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
11. Dagar, K., Asati, V., Bharti, S. K., Suryavanshi, A., Shukla, D., Mahapatra, D. K., & Kumar, V. (2024). Functional food for mitochondrial dysfunction and autophagy in neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 31-61): Elsevier.
12. Delafontaine, A., Vialleron, T., Barbier, G., Lardon, A., Barrière, M., García-Escudero, M., . . . Descarreaux, M. (2024). Effects of Manual Therapy on Parkinson’s Gait: A Systematic Review. Sensors, 24(2), 354.
13. Duvdevani, M., Yogev-Seligmann, G., Schlesinger, I., Nassar, M., Erich, I., Hadad, R., & Kafri, M. (2024). Association of health behaviors with function and health-related quality of life among patients with Parkinson’s disease. Israel Journal of Health Policy Research, 13(1), 1-10.
14. Farombi, E. O., Ajeigbe, O. F., Anamelechi, J., Adeyemo, O., Ojo, M. O., Atarase, O., & Ikeji, C. N. (2024). Neuroprotection by ginger and its components in neurodegenerative diseases Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1525-1543): Elsevier.
15. Federico, S., Cacciante, L., Cieślik, B., Turolla, A., Agostini, M., Kiper, P., & Picelli, A. (2024). Telerehabilitation for Neurological Motor Impairment: A Systematic Review and Meta-Analysis on Quality of Life, Satisfaction, and Acceptance in Stroke, Multiple Sclerosis, and Parkinson’s Disease. Journal of Clinical Medicine, 13(1), 299.
16. Golpour-Hamedani, S., Pourmasoumi, M., Zarifi, S. H., Askari, G., Jamialahmadi, T., Bagherniya, M., & Sahebkar, A. (2024). Therapeutic effects of saffron and its components on neurodegenerative diseases. Heliyon.
17. Hanff, A.-M., McCrum, C., Dessenne, C., Pauly, C., Pauly, L., Leist, A. K., . . . Zeegers, M. (2040). DETERMINANTS OF PATIENT-REPORTED FUNCTIONAL MOBILITY IN PEOPLE WITH PARKINSON’S DISEASE: PROTOCOL FOR A SYSTEMATIC REVIEW OF AETIOLOGY AND RISK. development, 7.
18. Helgudóttir, S. S., Mørkholt, A. S., Lichota, J., Bruun-Nyzell, P., Andersen, M. C., Kristensen, N. M. J., . . . Nieland, J. D. V. (2024). Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system. Neural Regeneration Research, 19(7), 1437-1445.
19. Hiu, S., Yong, T., Hasoon, J., Teare, M. D., Taylor, J. P., & Lin, N. (2024). Instrumental variables in real‐world clinical studies of dementia and neurodegenerative disease: Systematic review of the subject‐matter argumentation, falsification test, and study design strategies to justify a valid instrument. Brain and Behavior, 14(1), e3371.
20. Karande, S., & Kulkarni, V. (2024). Advancing Neurodegenerative Disorder Diagnosis: A Machine Learning-Driven Evaluation of Assessment Modalities. International Journal of Intelligent Systems and Applications in Engineering, 12(5s), 309-323.
21. Katiyar, S., Kumari, S., Dev, A., Tripathi, R. S., Srivastava, P. K., & Mishra, A. (2024). Herbal Nanoparticles Drug-Loaded for the Treatment of Neurodegenerative Diseases. Nanoarchitectonics for Brain Drug Delivery, 266.
22. Kezele, T. G., & Ćurko-Cofek, B. (2024). Neuroprotection induced by olive oil components Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1679-1702): Elsevier.
23. Kluger, B. M., Katz, M., Galifianakis, N. B., Pantilat, S. Z., Hauser, J. M., Khan, R., . . . Long, S. J. (2024). Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease. JAMA neurology, 81(1), 39-49.
24. Leonard, H., Jonson, C., Levine, K., Lake, J., Hertslet, L., Jones, L., . . . Terry, N. (2024). Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature. medRxiv, 2024.2001. 2008.24301007.
25. Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024). Iron imbalance in neurodegeneration. Molecular Psychiatry, 1-14.
26. Liang, J., Wan, Z., Qian, C., Rasheed, M., Cao, C., Sun, J., . . . Deng, Y. (2024). The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease. Cellular & Molecular Biology Letters, 29(1), 1-24.
27. Liu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., . . . Chen, L. (2024). Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach. Brain, Behavior, and Immunity.
28. Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., . . . Tang, M. (2024). Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Neural Regeneration Research, 19(4), 833-845.
29. Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2024). Nutrition, Immunity and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
30. Mohamed, W. M. Y. (2024). Connecting the Dots: AfrAbia's Environmental Challenges and Parkinson's Disease.
31. Pandit, N., Kulkarni, S., & Singhvi, G. (2024). Effect of green tea on human brain health Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 301-331): Elsevier.
32. Parihar, A., Gaur, K., & Khan, R. (2024). Rapid diagnostic assays for the detection of Alzheimer’s and Parkinson’s diseases Smart Diagnostics for Neurodegenerative Disorders (pp. 221-250): Elsevier.
33. Pigott, J. S., Davies, N., Chesterman, E., Read, J., Nimmons, D., Walters, K., . . . Schrag, A. (2024). Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals. Health Expectations, 27(1), e13950.
34. Rafe, M. R. (2024). Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics, 8(1), 90.
35. Shafiee, A., Rafiei, M. A., Jafarabady, K., Eskandari, A., Abhari, F. S., Sattari, M. A., . . . Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta‐analysis. Brain and Behavior, 14(1), e3340.
36. Shukla, D., Jaiswal, A. K., Suryavanshi, A., Asati, V., Mahapatra, D. K., Kumar, V., & Bharti, S. K. (2024). Role of garlic and onion for better cognition and maintenance of neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 333-352): Elsevier.
37. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-16.
38. Tasleem, A., Kaushik, M., Kaushik, P., Tabassum, H., & Parvez, S. (2024). Neuroprotective efficacy of melatonin in the pathophysiology of neurodegenerative disorders Natural Molecules in Neuroprotection and Neurotoxicity (pp. 615-633): Elsevier.
39. Tosin, M. H., Goetz, C. G., & Stebbins, G. T. (2024). Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life: Systematic Review. Neurology, 102(3), e208028.
40. Wang, H., Liu, Y.-T., Ren, Y.-L., Guo, X.-Y., & Wang, Y. (2024). Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis. Journal of Neuroimmunology, 578290.
41. Wei, B.-r., Zhao, Y.-j., Cheng, Y.-f., Huang, C., & Zhang, F. (2024). Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing, 21(1), 1.
2. Arunachalam, K. D., Saranya, S., & Karuppannan, S. K. (2024). Role of dietary fibres in the management of hypertension and its association with neurodegeneration Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 261-275): Elsevier.
3. Banou, E., Vrahatis, A. G., Krokidis, M. G., & Vlamos, P. (2024). Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease. BioMedInformatics, 4(1), 127-138.
4. Bartolomeu Pires, S., Kunkel, D., Kipps, C., Goodwin, N., & Portillo, M. C. (2024). Person‐centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review. Health Expectations, 27(1), e13948.
5. Cabanillas, J., Risco, R., Munive-Degregori, A., Guerrero, M. E., Mauricio, F., & Mayta-Tovalino, F. Periodontitis and neuropathic diseases: A literature review. Journal of International Society of Preventive and Community Dentistry, 10.4103.
6. Caminiti, S. P., Gallo, S., Menegon, F., Naldi, A., Comi, C., & Tondo, G. (2024). Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
7. Chen, S. T., & Small, G. W. (2024). Precision Nutrition in Aging and Brain Health Precision Nutrition (pp. 241-276): Elsevier.
8. Cheng, W.-H., Quan, Y., & Thompson, W. F. (2024). The Effect of Dance on Mental Health and Quality of Life of People with Parkinson's Disease: A Systematic Review and Three-level Meta-Analysis. Archives of Gerontology and Geriatrics, 105326.
9. Chiang, L., Cheong, D., Cordato, N. J., & Smerdely, P. (2024). A systematic review of visual art therapy and its effects in older people with mild cognitive impairment. International Journal of Geriatric Psychiatry, 39(1), e6053.
10. Ciocca, M., & Pizzamiglio, C. (2024). Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
11. Dagar, K., Asati, V., Bharti, S. K., Suryavanshi, A., Shukla, D., Mahapatra, D. K., & Kumar, V. (2024). Functional food for mitochondrial dysfunction and autophagy in neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 31-61): Elsevier.
12. Delafontaine, A., Vialleron, T., Barbier, G., Lardon, A., Barrière, M., García-Escudero, M., . . . Descarreaux, M. (2024). Effects of Manual Therapy on Parkinson’s Gait: A Systematic Review. Sensors, 24(2), 354.
13. Duvdevani, M., Yogev-Seligmann, G., Schlesinger, I., Nassar, M., Erich, I., Hadad, R., & Kafri, M. (2024). Association of health behaviors with function and health-related quality of life among patients with Parkinson’s disease. Israel Journal of Health Policy Research, 13(1), 1-10.
14. Farombi, E. O., Ajeigbe, O. F., Anamelechi, J., Adeyemo, O., Ojo, M. O., Atarase, O., & Ikeji, C. N. (2024). Neuroprotection by ginger and its components in neurodegenerative diseases Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1525-1543): Elsevier.
15. Federico, S., Cacciante, L., Cieślik, B., Turolla, A., Agostini, M., Kiper, P., & Picelli, A. (2024). Telerehabilitation for Neurological Motor Impairment: A Systematic Review and Meta-Analysis on Quality of Life, Satisfaction, and Acceptance in Stroke, Multiple Sclerosis, and Parkinson’s Disease. Journal of Clinical Medicine, 13(1), 299.
16. Golpour-Hamedani, S., Pourmasoumi, M., Zarifi, S. H., Askari, G., Jamialahmadi, T., Bagherniya, M., & Sahebkar, A. (2024). Therapeutic effects of saffron and its components on neurodegenerative diseases. Heliyon.
17. Hanff, A.-M., McCrum, C., Dessenne, C., Pauly, C., Pauly, L., Leist, A. K., . . . Zeegers, M. (2040). DETERMINANTS OF PATIENT-REPORTED FUNCTIONAL MOBILITY IN PEOPLE WITH PARKINSON’S DISEASE: PROTOCOL FOR A SYSTEMATIC REVIEW OF AETIOLOGY AND RISK. development, 7.
18. Helgudóttir, S. S., Mørkholt, A. S., Lichota, J., Bruun-Nyzell, P., Andersen, M. C., Kristensen, N. M. J., . . . Nieland, J. D. V. (2024). Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system. Neural Regeneration Research, 19(7), 1437-1445.
19. Hiu, S., Yong, T., Hasoon, J., Teare, M. D., Taylor, J. P., & Lin, N. (2024). Instrumental variables in real‐world clinical studies of dementia and neurodegenerative disease: Systematic review of the subject‐matter argumentation, falsification test, and study design strategies to justify a valid instrument. Brain and Behavior, 14(1), e3371.
20. Karande, S., & Kulkarni, V. (2024). Advancing Neurodegenerative Disorder Diagnosis: A Machine Learning-Driven Evaluation of Assessment Modalities. International Journal of Intelligent Systems and Applications in Engineering, 12(5s), 309-323.
21. Katiyar, S., Kumari, S., Dev, A., Tripathi, R. S., Srivastava, P. K., & Mishra, A. (2024). Herbal Nanoparticles Drug-Loaded for the Treatment of Neurodegenerative Diseases. Nanoarchitectonics for Brain Drug Delivery, 266.
22. Kezele, T. G., & Ćurko-Cofek, B. (2024). Neuroprotection induced by olive oil components Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1679-1702): Elsevier.
23. Kluger, B. M., Katz, M., Galifianakis, N. B., Pantilat, S. Z., Hauser, J. M., Khan, R., . . . Long, S. J. (2024). Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease. JAMA neurology, 81(1), 39-49.
24. Leonard, H., Jonson, C., Levine, K., Lake, J., Hertslet, L., Jones, L., . . . Terry, N. (2024). Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature. medRxiv, 2024.2001. 2008.24301007.
25. Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024). Iron imbalance in neurodegeneration. Molecular Psychiatry, 1-14.
26. Liang, J., Wan, Z., Qian, C., Rasheed, M., Cao, C., Sun, J., . . . Deng, Y. (2024). The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease. Cellular & Molecular Biology Letters, 29(1), 1-24.
27. Liu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., . . . Chen, L. (2024). Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach. Brain, Behavior, and Immunity.
28. Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., . . . Tang, M. (2024). Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Neural Regeneration Research, 19(4), 833-845.
29. Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2024). Nutrition, Immunity and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
30. Mohamed, W. M. Y. (2024). Connecting the Dots: AfrAbia's Environmental Challenges and Parkinson's Disease.
31. Pandit, N., Kulkarni, S., & Singhvi, G. (2024). Effect of green tea on human brain health Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 301-331): Elsevier.
32. Parihar, A., Gaur, K., & Khan, R. (2024). Rapid diagnostic assays for the detection of Alzheimer’s and Parkinson’s diseases Smart Diagnostics for Neurodegenerative Disorders (pp. 221-250): Elsevier.
33. Pigott, J. S., Davies, N., Chesterman, E., Read, J., Nimmons, D., Walters, K., . . . Schrag, A. (2024). Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals. Health Expectations, 27(1), e13950.
34. Rafe, M. R. (2024). Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics, 8(1), 90.
35. Shafiee, A., Rafiei, M. A., Jafarabady, K., Eskandari, A., Abhari, F. S., Sattari, M. A., . . . Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta‐analysis. Brain and Behavior, 14(1), e3340.
36. Shukla, D., Jaiswal, A. K., Suryavanshi, A., Asati, V., Mahapatra, D. K., Kumar, V., & Bharti, S. K. (2024). Role of garlic and onion for better cognition and maintenance of neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 333-352): Elsevier.
37. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-16.
38. Tasleem, A., Kaushik, M., Kaushik, P., Tabassum, H., & Parvez, S. (2024). Neuroprotective efficacy of melatonin in the pathophysiology of neurodegenerative disorders Natural Molecules in Neuroprotection and Neurotoxicity (pp. 615-633): Elsevier.
39. Tosin, M. H., Goetz, C. G., & Stebbins, G. T. (2024). Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life: Systematic Review. Neurology, 102(3), e208028.
40. Wang, H., Liu, Y.-T., Ren, Y.-L., Guo, X.-Y., & Wang, Y. (2024). Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis. Journal of Neuroimmunology, 578290.
41. Wei, B.-r., Zhao, Y.-j., Cheng, Y.-f., Huang, C., & Zhang, F. (2024). Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing, 21(1), 1.
Article Sidebar
Published
Feb 6, 2024
Article Details
How to Cite
Sudhair Abbas Bangash, Dr. Syed Sikandar Shah, Sidra Hassan, Md Moktadirul Alam, Muhammad Umar, Dr. Rebecca Caruana, Dr. Abdalrahim A.M Bsharat, Dr. Saja Khalid Ahmed Al-Abbasi, & Tariq Rafique. (2024). IMPACT OF THE NUTRITIONAL APPROACH IN PATIENTS WITH PARKINSON’S NEURODEGENERATIVE DISEASE; LITERATURE REVIEW. Journal of Population Therapeutics and Clinical Pharmacology, 31(2), 216-234. https://doi.org/10.53555/jptcp.v31i2.4329
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Sudhair Abbas Bangash
Faculty of Life Science, Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
Dr. Syed Sikandar Shah
Assistant Professor, Department of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, UAE.
Sidra Hassan
Teacher, Chemistry, Fatima Educator, Talagang, Pakistan
Md Moktadirul Alam
College of Food Science & Technology, Shanghai Ocean University, China.
Muhammad Umar
Medical Graduate, Windsor University School of Medicine (Saint Kitts)
Dr. Rebecca Caruana
Department of Medicine, Mater Dei Hospital, Imsida, Malta.
Dr. Abdalrahim A.M Bsharat
I.k. Akhunbaev Kyrgyz State Medical Academy, Internal Medicine, Palestinian.
Dr. Saja Khalid Ahmed Al-Abbasi
Medical Trainee, UAE, UMF Carol Davila University Graduate, Romania,
Tariq Rafique
Assistant Professor Dadabhoy Institute of Higher Education, Karachi, Pakistan
How to Cite
Sudhair Abbas Bangash, Dr. Syed Sikandar Shah, Sidra Hassan, Md Moktadirul Alam, Muhammad Umar, Dr. Rebecca Caruana, Dr. Abdalrahim A.M Bsharat, Dr. Saja Khalid Ahmed Al-Abbasi, & Tariq Rafique. (2024). IMPACT OF THE NUTRITIONAL APPROACH IN PATIENTS WITH PARKINSON’S NEURODEGENERATIVE DISEASE; LITERATURE REVIEW. Journal of Population Therapeutics and Clinical Pharmacology, 31(2), 216-234. https://doi.org/10.53555/jptcp.v31i2.4329